Love Me Love My Phages

  • Home
  • Love Your Phages
  • George Eliava Institute
  • eat-me-the-soviet-method-for-attacking-infection
  • Phage Therapy
  • phage-therapy-and-cholera---1
  • Cocktail That Cures
  • Phage Therapy in Agriculture and Animals - 1
  • Phage Therapy_Past History and Future Prospects
  • bdellovibrio-a-predatory-bacteria -1
  • uk - first-superbug-phage-clinical-trial
  • Bacteriophages and Sleeping Sickness
  • The MRSA Problem
  • The Use of Bacteriophages Against Infections
  • Virises vs Superbugs
  • Bacterias natural born killers
  • The Killers Within Prologue
  • The Killers Within - The Silent War
  • Bacteriophages as Antibiotics
  • The Cocktail That Cures
  • Phage Therapy - Abstracts From The Scientific Area
  • Phage production goes large scale
  • Novel alternatives to antibiotics
  • Phages channel their resources
  • Viral defense against Listeria in Foods
  • Bacteriophage Therapy a Revitalized Therapy
  • US Phage Therapy Clinics in Mexico
  • E coli Phage Therapy Implications
  • Phage Therapy and E coli in Livestock
  • Bacteriophage Therapy in Western Medicine
  • Scientists Discover Exciting New MRSA Fighter
  • The New Antibiotics
  • Support Those Who Help Us Make This Site Possible
  • SCIENCE FRIDAY - MP3 FILES
  • Division M- Bacteriophage
  • A Glossary Defining Some Terms For Phage Biology
  • Bacteriophages on the World Wide Web
  • Major Discoveries Made With Bacteriophages
  • W W C Topley and the Missing Phage Reference
  • Lives At Risk From Drug Resistant Bug
  • A Killer In Our Midst
  • Adelaide RAH Superbug Outbreak Worsens
  • Bug At Adelaide RAH Infects More
  • US Meat Sector Target Of Listeria Technology
  • Microscope Dangers
  • Therapy with a Nonreplicating GM Phage
  • Phage Therapy - The Escherichia coli Experience
  • E-coli Phage Human Safety Tests in Water
  • Thank Yous
  • Phages in Treating Trial of e coli in Chickens
  • Phages_Pseudomonas aeruginosa Septicemia in Mice
  • Hello World
  • Using Phage Viruses to Help Fight Infection
  • Georgia an Unlikely Stronghold for Bacteriophage
  • Bacteriophage method to antimicrobial drugs
  • 48 Hours CBS on Bacteriophages
  • An infant in septic shock _ Commentary
  • An infant in septic shock _ Where Now
  • Hospital horror
  • Anthrax stopper
  • Phage R and D Companies
  • Viruses vs Superbugs
  • The Next Phage
  • Statins Reduce Infection
  • Statins vs Bacteria
  • STATINS REDUCE SEPIS IN DIALYSIS
  • Statins Can Prevent A Second Stroke
  • Contact - Love Me Love My Phages
  • Statins May Help One Brit in Six Reach 100
  • Statins Help Slow Down Multiple Sclerosis
  • New Way To Fight Superbugs inc With Tears
  • Phages vs Fireblight Disease - 1
  • Company Develops Natural Way to Fight E coli
  • First 'virophage' could take the fight to viruses
  • Sputnik virophage
  • Virophage - the virus eater
  • Phage Biotech Israel


FDA approves viral defense against Listeria in RTE foods

Zachary Richardson. Food Chemical News.  August 28, 2006 v48 i29 p15.

Full Text: COPYRIGHT 2006 Agra Informa, Inc.



FDA has approved a food additive petition that will allow for the use of a mixture containing bacteriophages (bacteria-eating viruses) in combating Listeria monocytogenes, marking the first time such an approval has been issued in the United States--but, according to the additive's manufacturer, not the last.

Bacteriophages are viruses that target and infect bacteria with their own genetic material. They "hijack" the bacteria's DNA, forcing it to produce more bacteriophages, which then lyse (destroy) the bacteria by bursting it from within.

The approved mixture, manufactured by Intralytix, Inc., contains six varieties of bacteriophages, each specific against different strains of Listeria, including strains responsible for foodborne illness.

"They all target Listeria monocytogenes, but we collected almost 300 different samples of Listeria and then we took those samples and tested our phage library against them," Intralytix president and CEO John Vazzana told Food Chemical News. "Based on that testing, we selected the six phages that we believed would give us the best protection," he said.

According to FDA, "The phage preparation will be used as an antimicrobial agent to control L. monocytogenes in the production of ready-to-eat (RTE) meat and poultry products. The phage preparation is directly sprayed on the surface of the RTE food articles at a level of approximately 1 milliliter of the preparation per 500 square centimeters of food surface area just prior to packaging."

"The target market has always been RTE foods," Vazzana continued. "During the four years of the approval process--which is a very long time for an approval--we've seen the problems with Listeria in RTE foods growing. If you back to the records that the CDC maintains, 99% of the Listeria monocytogenes cases have been in RTE foods, so that's always been what we've targeted," he said.

The preparation must comply with the Federal Meat Inspection Act and the Poultry Products Inspection Act, FDA noted, both of which are regulated by USDA, and must be listed on the label as an ingredient. FSIS has been convinced of the treatment's safety, FDA said.

Oddly enough, phage technology is both time-tested and novel, Vazzana said. "Phage technology has been around for 100 years; it was used in the U.S. for human health prior to the advent of antibiotics, and it's been used in Europe and the former Soviet Union since the early Twenties," he said.

FDA noted that while it was the first time the agency has allowed the use of a phage preparation in foods, phages are utilized on crops and in pesticide applications.

The technology could also represent another line of defense in light of increasing rates of antibiotic resistance, Vazzana suggested. "Phages are the most ubiquitous organism on the planet today--they're nature's way of controlling bacteria. One of the things that we think is an advantage ... is that they are very specific, those same phages will not lyse or kill any other strain of bacteria, unlike antibiotics, which are very broad-spectrum. Several bacteria have become resistant to antibiotics, and that's a problem that's growing every day," he said.

E. coli and Salmonella in the crosshairs

Intralytix is currently conducting research on similar treatments for other foodborne pathogens, notably E. coli 0157:H7 and Salmonella, Vazzana said. "Preparations for both have been developed, and we're going through some efficacy testing and screening at this point. We would hope to file a petition with FDA in the next four to six months for the E. coli product," with the Salmonella preparation to follow.

Those products would make the leap from RTE foods to those that require cooking, he added. "We're testing putting [the E. coli preparation] on beef before it would be ground up; the belief is and so far the tests indicate that we can eliminate the presence of E. coli by grinding the phages into the meat. We believe that we could significantly reduce the E. coli contamination and then maybe my wife will be able to make rare burgers again," Vazzana said.

Moreover, he added, the approval process for bacteriophage products may be a little less grueling in the future. "Four years is an extraordinarily long time to get a food additive approved, but this is a new technology, and frankly we were kind of neophytes in regard to what FDA expected from us," he explained. "We now feel like we know what FDA wants and FDA knows what we can provide."

Zachary Richardson

zachary.richardson@informa.com

 

http://galenet.galegroup.com/servlet/HWRC/hits?r=d&origSearch=false&o=&bucket=per&rlt=2&n=10&l=d&items=0&c=15&tcit=0_1_0_0_0_0&docNum=A150990591&sgPhrase=false&locID=cityadelaide&secondary=false&t=RK&s=1&SU=Phage+Therapy


Make a Free Website with Yola.